May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
The Effects of Retinoids on Corneal Neovascularization Induced in the Rat
Author Affiliations & Notes
  • N. Gupta
    Ophthalmology, Medical College of Georgia, Augusta, GA
  • A. Proia
    Pathology, Duke University Medical Center, Durham, NC
  • Footnotes
    Commercial Relationships  N. Gupta, None; A. Proia, None.
  • Footnotes
    Support  NEI Grant RO1 EY05883
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 4809. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. Gupta, A. Proia; The Effects of Retinoids on Corneal Neovascularization Induced in the Rat . Invest. Ophthalmol. Vis. Sci. 2004;45(13):4809.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Retinoids, naturally occurring and synthetic vitamin A analogs, inhibit angiogenesis in various models. In this study, we examined the ability of topical and intraperitoneal (IP) all–trans retinoic acid and topical 9–cis retinoic acid to inhibit corneal neovascularization induced in the rat by silver nitrate cauterization. Methods: Following corneal injury, rats were randomized into four groups and were given either control vehicle or topical or intraperitoneal retinoids for four days. 30µl of topical all–trans retinoic acid was applied four times per day in 0.1% DMSO or 5% DMSO/corn oil vehicle at concentrations of 1, 10, 100, or 1000 µg/ml while 30µl of topical 9–cis retinoic acid was administered four times per day in 5% DMSO/corn oil at concentration of 10, 100, or 1000 µg/ml. IP all–trans retinoic acid in 0.1% DMSO was given once per day at a dose of 1 or 10 mg/kg/day. Upon completion of the treatment period, the rats were perfused with India ink intravenously. The corneas were harvested and mounted on a glass slide. A masked observer utilized computer image analysisto measure the total length of vessels in mm/mm2 of corneal area. Results: Topical all–trans retinoic acid in 0.1% DMSO at a concentration of 1000 µg/ml (120 µg/day) demonstrated 12.2 ± 0.86 mm/mm2 of corneal neovascularization (P>0.05), while1000 µg/ml of all–trans retinoic acid in 5% DMSO and corn oil suspension had 14.7 ± 0.65 mm/mm2 of corneal neovascularization (P>0.05). 1000 µg/ml of 9–cis retinoic acid in 5% DMSO and corn oil suspension also lacked a significant inhibitory response (15.0 ± 0.45 mm/mm2, P>0.05). Lower topical concentrations in all treatment groups also lacked an angiostatic response. Finally, IP all–trans retinoic acid in 0.1% DMSO administered at 10 mg/kg/day demonstrated 8.5 ±1.28 mm/mm2 of corneal neovascularization (P >0.5). Conclusions:Our results do not support a role for retinoids as therapeutic agents in the treatment for corneal neovascularization induced by the severe injury utilized in this study.

Keywords: retinoids/retinoid binding proteins • neovascularization • cornea: basic science 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×